Ekso Bionics (NASDAQ:EKSO – Get Free Report) announced its earnings results on Monday. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.02), Yahoo Finance reports. Ekso Bionics had a negative net margin of 68.41% and a negative return on equity of 88.93%. The company had revenue of $4.95 million for the quarter, compared to the consensus estimate of $5.34 million. During the same quarter in the previous year, the firm earned ($0.31) earnings per share.
Ekso Bionics Price Performance
Shares of EKSO stock traded down $0.01 during trading hours on Wednesday, hitting $1.05. 100,366 shares of the company’s stock were exchanged, compared to its average volume of 132,800. The company has a market capitalization of $19.08 million, a PE ratio of -1.08 and a beta of 1.51. Ekso Bionics has a 12-month low of $0.62 and a 12-month high of $3.13. The business’s 50 day simple moving average is $1.15 and its 200-day simple moving average is $1.47. The company has a current ratio of 2.81, a quick ratio of 2.11 and a debt-to-equity ratio of 0.33.
Analyst Ratings Changes
Several brokerages have issued reports on EKSO. StockNews.com began coverage on shares of Ekso Bionics in a research report on Tuesday. They set a “hold” rating for the company. HC Wainwright reiterated a “buy” rating and set a $10.00 target price on shares of Ekso Bionics in a research report on Tuesday. Finally, Lake Street Capital initiated coverage on shares of Ekso Bionics in a research report on Monday, June 24th. They set a “buy” rating and a $2.50 target price for the company.
About Ekso Bionics
Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.
Read More
- Five stocks we like better than Ekso Bionics
- EV Stocks and How to Profit from Them
- Joby Aviation Stock: The Case for Upside Just Got Stronger
- Why Are Stock Sectors Important to Successful Investing?
- Conviction Firms for Microsoft’s Double-Digit Stock Upside
- Pros And Cons Of Monthly Dividend Stocks
- 5 Aggressive Growth Stocks for Long-Term Investors
Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter.
